press Groundbreaking Innovation Takes Center Stage: Winner Announced in Scientific Sessions 2023 Health Tech Competition FOR IMMEDIATE RELEASE Groundbreaking Innovation Takes Center Stage: Winner Announced in Scientific Sessions 2023 Health Tech Competition PHILADELPHIA, November 13, 2023 — In a remarkable showcase of ingenuity and technological advancement,
press RCE presents late breaking findings at 2023 TCT Shark Tank San Francisco, CA (October 23, 2023) - RCE Technologies, Inc. had the opportunity to go center stage and present an overview of the company's innovative technology along with late breaking
press RCE.ai Selected as a Promising Health Tech Company in the Cedars-Sinai Accelerator Program Carlsbad, CA (July 11, 2023) - RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection
press Detecting Heart Attacks In Cardiac Arrest Patients Carlsbad, California (April 11, 2023) - RCE Technologies, Inc. Heart disease is a leading cause of death worldwide, and heart attacks are a particularly dangerous form of heart disease. When
updates RCE at the 17th Annual Biomarkers Symposium Torrey Pines, California (March 25, 2023) The 17th Annual Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium showcased the latest clinical data, guidelines and evidence related to the clinical application
press RCE Takes the Stage at the 2023 American College of Cardiology with Exciting Late Breaking Clinical Trial Results New Orleans, LA (March 6, 2023) - RCE Technologies, Inc's groundbreaking study titled "A Novel Breakthrough In Wrist-Worn Transdermal Troponin-I-Sensor Assessment For Acute Myocardial Infarction" was presented at the American
press RCE welcomes Ronald P. Karlsberg, MD as clinical advisor Carlsbad, California (March 2, 2023) - RCE Technologies, Inc. has just announced a major addition to the clinical team: the highly acclaimed Ronald P. Karlsberg, MD, FACC. As a Clinical
press RCE to present at the 2023 American College of Cardiology - Late Breaking Clinical Trials Carlsbad, California (December 20, 2022) - RCE Technologies, Inc. has been accepted to present at the American College of Cardiology - Late Breaking Clinical Trials. The presentation titled, "A Novel
press RCE featured at innovation showcase September 14, 2022 | New Brunswick, NJ With rapid transformation of cardiovascular medicine from reactive to preventive, the Rutgers Robert Wood Johnson University Hospital is investing in the vision of a
press RCE secures its milestone patent Feburary 22, 2022 | Carlsbad, CA RCE, the AI med tech company developing point of care Troponin diagnostics, has announced the award of its first patent from the U. S. Patent
press Introducing the TMCx Fall 2020 cohort RCE is 1 of 7 companies selected from around the world into TMCx Fall 2020 cohort.
press GaBio Summit Winners 2020 Georgia Bio announces RCE as the winner of its 2020 GaBio Summit Pitch Rounds competition.
press RCE inducted to ATDC RCE is excited to join the Advanced Technology Development Center (ATDC) accelerate program, Georgia Tech's startup incubator
press SEMDA Winners 2019 RCE wins the 2019 SEMDA PitchRounds competition and works towards bringing a valuable diagnostic solution to market
